Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01058668Phase 3Completed
A Phase 3 trial of cariprazine in bipolar I disorder, sponsored by Forest Laboratories. Started Feb 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01058668.